The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of messenger ribonucleic acid (mRNA) synthesis raw materials has been steadily expanding over past years. The market size is expected to increase from $2.99 billion in 2024 and reach $3.06 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 2.5%.
The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market is projected to grow to $3.54 billion by 2029, with a compound annual growth rate (CAGR) of 3.7%.
Download Your Free Sample of the 2025 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report and Uncover Key Trends Now!The key drivers in the messenger ribonucleic acid (mrna) synthesis raw materials market are:
• Supply chain optimization and market expansion in the sector
• Increased investments in biotech and pharma industries
• Regulatory approvals and support contribute to market growth
• Expansion in the field of therapeutics.
The messenger ribonucleic acid (mRNA) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
The key trends in the messenger ribonucleic acid (mrna) synthesis raw materials market are:
• The market is expected to be shaped by the entry of new players.
• A trend towards stringent quality control measures and standardization is becoming apparent.
• The dynamics of the market are being influenced by matters surrounding intellectual property and licensing.
• There is a noticeable shift towards sustainable and scalable manufacturing methods.
The major players in the messenger ribonucleic acid (mrna) synthesis raw materials market are:
• Pfizer Inc
North America was the largest region in the mRNA synthesis raw materials market in 2024